Literature DB >> 19944790

Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan.

Yung-Hsiu Lin1, Li-Min Huang, I-Shou Chang, Fang-Yu Tsai, Chun-Yi Lu, Pei-Lan Shao, Luan-Yin Chang.   

Abstract

Herpes zoster, a common disease, has an important impact on the health of adults, particularly the elderly, and the health system. This study evaluated the disease burden and epidemiological characteristics of herpes zoster in Taiwan. Using herpes zoster-related ICD-9-CM codes used on Taiwan's National Health Insurance claims, we analyzed overall and age group differences in incidence, complications, utilization of healthcare facilities, lengths of stay, and cost of their medical care in Taiwan's population from 2000 to 2005. The overall annual incidence of zoster was 4.97 cases per 1000 people, with women having a significantly higher incidence than men (5.20 per 1000 vs. 4.72 per 1000, p<0.001). The incidence increased stepwise with age, with 5.18 cases per 1000 in people 40-50 years old, 8.36 in those 50-60, 11.09 in those 60-70, and 11.77 in those above 70 years old. The estimated lifetime risk of developing herpes zoster was 32.2%. Zoster-related hospitalizations and medical cost per patient increased with age. In conclusion, about two-thirds of Taiwan's zoster cases occur in adults older than 40 years old and about one-third of the population would develop zoster within their lifetime. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19944790     DOI: 10.1016/j.vaccine.2009.11.029

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  34 in total

Review 1.  Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective.

Authors:  Robert W Johnson; Marie-José Alvarez-Pasquin; Marc Bijl; Elisabetta Franco; Jacques Gaillat; João G Clara; Marc Labetoulle; Jean-Pierre Michel; Luigi Naldi; Luis S Sanmarti; Thomas Weinke
Journal:  Ther Adv Vaccines       Date:  2015-07

2.  Herpes zoster increased risk of neuralgic amyotrophy: a retrospective, population-based matched cohort study.

Authors:  Tsung-Yen Ho; Chi-Hsiang Chung; Yu-Ping Shen; Liang-Cheng Chen; Wu-Chien Chien; Yung-Tsan Wu
Journal:  J Neurovirol       Date:  2018-11-05       Impact factor: 2.643

Review 3.  Evaluation of the economic burden of Herpes Zoster (HZ) infection.

Authors:  Donatella Panatto; Nicola Luigi Bragazzi; Emanuela Rizzitelli; Paolo Bonanni; Sara Boccalini; Giancarlo Icardi; Roberto Gasparini; Daniela Amicizia
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 4.  Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia.

Authors:  D Gilden
Journal:  J Intern Med       Date:  2011-02-23       Impact factor: 8.989

5.  Balanitis is a risk factor for herpes zoster.

Authors:  C-Y Hsu; C-L Lin; C-H Kao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-18       Impact factor: 3.267

6.  A systematic literature review of herpes zoster incidence worldwide.

Authors:  Désirée van Oorschot; Hilde Vroling; Eveline Bunge; John Diaz-Decaro; Desmond Curran; Barbara Yawn
Journal:  Hum Vaccin Immunother       Date:  2021-03-02       Impact factor: 3.452

7.  Radiotherapy Increases the Incidence of Herpes Zoster in Oral Cavity Cancer Patients - a National Population-based Cohort Study.

Authors:  Yung-Shuo Kao; Yen Hsu; Chung Y Hsu
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

8.  Herpes zoster is associated with an increased risk of subsequent lymphoid malignancies - a nationwide population-based matched-control study in Taiwan.

Authors:  Yi-Chang Liu; Yi-Hsin Yang; Hui-Hua Hsiao; Wen-Chi Yang; Ta-Chih Liu; Chao-Sung Chang; Ming-Yu Yang; Pai-Mei Lin; Jui-Feng Hsu; Pi-Yu Chang; Sheng-Fung Lin
Journal:  BMC Cancer       Date:  2012-10-31       Impact factor: 4.430

Review 9.  Increased risk of herpes zoster infection in patients with inflammatory bowel disease: a meta-analysis of cohort studies.

Authors:  Longui Ning; Rongqiang Liu; Sha Li; Guodong Shan; Haojie Du; Jie Zhang; Wenguo Chen; Fenming Zhang; Jinghua Yu; Guoqiang Xu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-10-18       Impact factor: 5.103

10.  Risk of Shingles in Adults with Primary Sjogren's Syndrome and Treatments: A Nationwide Population-Based Cohort Study.

Authors:  Jen-Yin Chen; Li-Kai Wang; Ping-Hsun Feng; Chin-Chen Chu; Tain-Junn Cheng; Shih-Feng Weng; Su-Zhen Wu; Tsung-Hsueh Lu; Chia-Yu Chang
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.